These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-000446-20 A multi-centre randomised trial of therapeutic intervention at primary HIV-1 infection 2011-01-31 due-trials
Reported results Terminated 2004-000798-71 Efficacy of Levetiracetam in Pendular Nystagmus: A Randomized, Double-blind, Placebo-controlled trial with crossover 2005-12-20 due-trials
Other 2004-002051-13 A randomised double-blind placebo-controlled trial of oral misoprostol for cervical priming before outpatient hysteroscopy not-yet-due
Reported results 2005-001214-40 A trial to compare the effects of nebivolol versus atenolol on various cardiovascular measurements including insulin sensitivity 2009-01-21 due-trials
Reported results 2005-001222-83 A phase I/II safety and tolerability dose escalation study following the autologous infusion of expanded adult haemopoietic stem cells to patients with liver insufficiency 2015-09-01 due-trials
Reported results Terminated 2005-002585-11 CPAP;Heliox Effects on Stability and Therapeutics 2007-03-01 due-trials
Reported results 2005-003007-36 B.R.E.A.T.H.E. Bronchiolitis RCT: Emergency Assisted Therapy with Heliox - an Evaluation. A Prospective, Double-Blinded, Randomised, Controlled Clinical Trial to assess the effect of helium-oxygen gas... 2008-02-09 due-trials
Reported results Terminated 2005-003297-13 A randomised, double-blind, placebo-controlled, parallel-group study to investigate the effect of Symbicort® and Pulmicort® on HAT and HDAC expression and activity in induced sputum cells obtained fro... 2007-06-01 due-trials
Reported results 2005-003344-62 Effect of theophylline on histone deacetylase activity: enhancement of in-vitro glucocorticoid function in patients with COPD. 2007-08-29 due-trials
Exempt, with results 2006-000280-28 A Phase I/II safety and tolerability dose escalation study following the autologous infusion of expanded adult haematopoietic stem cells to patients with established myocardial ischaemia. 2014-08-21 not-yet-due
Exempt, with results 2006-000281-36 A Phase I/II safety and tolerability study following autologous infusion of adult haematopoietic cells to patients with acute total anterior circulation ischaemic stroke 2013-07-31 not-yet-due
Reported results Terminated 2006-001055-35 Lapatinib Pre-Surgical Phase 2 Study in Patients with Primary Breast Cancer 2010-10-13 due-trials
Reported results 2006-001386-42 The timing of intra-vitreal (4mg) triamcinolone acetonide, in addition to verteporfin photodynamic therapy for choroidal neovascularisation, in age-related macular degeneration: a prospective randomis... 2008-06-02 due-trials
Reported results Terminated 2006-001859-35 Abatacept in ANCA associated vasculitis: ABAVAS 2009-03-25 due-trials
Reported results 2006-002031-24 The HAM Ciclosporin Study: An observational trial of therapy in early or progressing HAM/TSP 2009-10-20 due-trials
Reported results 2006-002123-17 Mechanistic study assessing the immunological response of subjects after treatment with different formulations of sublingual immunotherapy. 2008-01-01 due-trials
Exempt, with results 2006-002328-40 A phase I safety and tolerability study of infusing the autologous progeny of an adult CD34+ subset into patients with type I diabetes mellitus and a successful renal transplant. 2013-05-31 not-yet-due
Reported results 2006-003561-13 Reversal of steroid insensitivity in COPD by theophylline 2007-08-29 due-trials
Reported results 2006-003596-12 A neoadjuvant study of chemotherapy versus endocrine therapy in postmenopausal patients with primary breast cancer 2011-08-31 due-trials
Exempt, with results 2006-003833-33 Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: A Phase I/II Clinical Trial Using AVI-4658 2009-03-31 not-yet-due
Completed, but no date, and reported results 2006-004442-16 Modulation of lung injury complicating lung resection bad-data
Reported results 2006-004521-28 A multi-centre phase I/II safety and tolerability study following the infusion of expanded autologous progeny of an adult CD34 positive stem cell subset to patients with recent tibial fractures. 2012-07-02 due-trials
Reported results 2006-004705-26 Safety and Tolerability of Sildenafil in Patients with Eisenmenger Physiology 2009-02-27 due-trials
Reported results 2006-005534-20 Effect of Erdosteine on inflammatory and oxidative biomarkers in sputum and exhaled breath in patients with COPD 2012-04-30 due-trials
Reported results 2006-006212-30 A Randomised, Open labelled, Phase II, Immunogenicity, and Exploratory Efficacy Evaluation of Therapeutic Immunisations +/- IL-2, GM-CSF and Growth Hormone in HIV-1 Infected Subjects Receiving Highly ... 2011-10-03 due-trials
Reported results 2006-006214-16 A randomised placebo controlled trial of rosuvastatin in systemic lupus erythematosus. 2014-05-16 due-trials
Reported results 2006-006221-77 Warfarin Anticoagualtion for liver fibrosis in patients transplanted for hepatitis C virus infection. 2012-07-01 due-trials
Reported results 2006-006347-31 A Phase II randomised placebo controlled clinical trial of Simvastatin in patients with secondary progressive multiple sclerosis 2012-11-14 due-trials
Reported results 2007-000438-38 Efficacy of Lopinavir in Pregnancy: Pharmacokinetic and Virological Studies with Kaletra melt extruded tablet formulation 2010-07-28 due-trials
Reported results Terminated 2007-000446-12 Treatment of Pulmonary Hypertension and Sickle Cell Disease with Sildenafil Therapy 2009-07-08 due-trials
Reported results Terminated 2007-000903-14 Randomized Phase III Trial to evaluate the effect of statins on tumour biology in non-small cell lung cancer. 2010-06-15 due-trials
Reported results 2007-001222-27 The effect of Pioglitazone on vascular and ventricular function in people with type 2 diabetes PICCOLA 2010-04-01 due-trials
Reported results Terminated 2007-002084-27 The pharmacokinetics and anti-inflammatory effects of prednisolone in severe asthma. 2013-11-12 due-trials
Reported results 2007-002405-47 A randomised prospective study assessing changes in neuro-cognitive function, using a computerised test battery, in treatment naïve HIV-1 positive subjects commencing two different antiretroviral regi... 2014-10-01 due-trials
Reported results Terminated 2007-002411-36 LungstarPK: Multi centre Phase II Trial of Pravastatin added to chemotherapy with Cisplatin and Docetaxel in patients with non-small cell lung cancer. 2010-08-31 due-trials
Reported results 2007-002466-35 A randomised placebo-controlled trial of fixed-dose combination medication in those at raised risk of cardiovascular disease 2010-04-30 due-trials
Exempt, with results 2007-004050-85 Evaluation of safety and gene expression with a single dose of pGM169/GL67A administered to the nose and lung of individuals with cystic fibrosis 2011-06-08 not-yet-due
Reported results 2007-004856-35 Scavenging free haemoglobin atenuates the systemic inflmmatory response following surgery 2011-05-02 due-trials
Reported results Terminated 2007-005554-23 AN OPEN, NON-RANDOMISED PILOT STUDY OF ANTI-TNF-ALPHA THERAPY IN EARLY OR PROGRESSING HAM/TSP 2010-12-21 due-trials
Reported results Terminated 2007-006664-29 The effect of inhaled corticosteroids (ICS) on airway smooth muscle in asthma 2010-07-31 due-trials
Reported results Terminated 2007-006692-37 The Immunomodulatory Role of Vitamin D in Inflammatory Bowel Disease (IBDVit): IBDVit1 - Trial of Adjuvant Vitamin D with Corticosteroids in Active Crohn’s Disease; IBDVit2 - Trial of Adjuvant Vitamin... 2010-05-01 due-trials
Exempt, with results 2007-007156-33 Melatonin As A Novel Neuroprotectant in Preterm Infants- Dosage study 2011-02-22 not-yet-due
Reported results 2007-007394-22 The role of white and grey matter and meningeal inflammation in multiple sclerosis (MS) and clinically isolated syndromes (CIS) as quantified using [(11)C](R)-PK11195 positron emission tomography (PET... 2013-10-03 due-trials
Reported results 2008-001160-36 A trial of Guanfacine, an alpha 2 adrenergic agonist, for Spatial Neglect and Impaired Vigilance following Stroke and Focal Brain Damage 2014-03-28 due-trials
Reported results Terminated 2008-001466-93 Trial of adjuvant vitamin D with Infliximab in active Crohn's Disease (IBDVit2). 2010-05-01 due-trials
Reported results Terminated 2008-001467-10 Trial of Adjuvant Vitamin D with Standard Maintenance Therapy in Preventing Relapse of Inflammatory Bowel Disease 2010-05-01 due-trials
Reported results 2008-002139-34 The Pharmacokinetics of Inhaled Fluticasone Propionate delivered as Monodisperse Aerosols 2011-07-03 due-trials
Reported results 2008-004229-40 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Ankylosing Spondylitis (AS) 2011-01-18 due-trials
Reported results 2008-004431-38 ACE inhibition and mechanisms of skeletal muscle weakness in COPD 2012-12-03 due-trials
Reported results Terminated 2008-004740-36 Melatonin As A Novel Neuroprotectant In Preterm Infants−Trial Study 2014-07-01 due-trials
Reported results 2008-004803-78 Effectiveness of Transtympanic Steroids in unilateral Ménière's disease: a Randomised Controlled Double-Blind Trial 2015-04-13 due-trials
Reported results Terminated 2008-005924-97 A 12 week observational study to evaluate the effects of the initiation of chemotherapy with anti-angiogenic activity on neovascularisation (as determined by contrast enhanced ultrasound, (CEUS)) with... 2009-11-19 due-trials
Reported results 2009-009235-30 Antidepressant controlled trial for negative symptoms in schizophrenia (ACTIONS) 2014-12-08 due-trials
Reported results 2009-011208-42 First trimester progesterone therapy in women with a history of unexplained recurrent miscarriages: A randomised, double-blind, placebo-controlled, multi-centre trial [The PROMISE (PROgesterone in rec... 2015-10-31 due-trials
Reported results 2009-011538-93 A prospective, randomised study to access safety, changes in platelet reactivity, plasma cardiac biomarkers and metabolic parameters over 48 weeks in HIV-1 infected subjects undergoing a switch in an... 2013-01-31 due-trials
Reported results Terminated 2009-011816-39 A randomised, open label, prospective study to assess two different therapeutic strategies following first treatment failure in HIV-1 infected subjects. ‘The First Failure Study’ : ‘FAST’ 2014-04-28 due-trials
Reported results 2009-012424-87 T cells and TNF: The impct of TNF blockade on effector T cell populations in rheumatoid arthritis and other conditions treated with anti-TNF-alpha agents. 2012-12-21 due-trials
Reported results 2009-012451-18 "EUROACTION PLUS con intervención intensiva sobre el tabaco (vareniclina) durante un programa de cardiología preventiva para pacientes con enfermedad aterosclerosa establecida, individuos con alto rie... 2011-07-31 due-trials
Other 2009-014042-28 What duration of intravenous antibiotic therapy should be used in the treatment of infective exacerbations of cystic fibrosis in patients chronically colonised with Pseudomonas aeruginosa? not-yet-due
Reported results 2009-014292-52 Tacrolimus vs prednisolone for the treatment of nephrotic syndrome secondary to minimal change disease: A Randomised Control Trial 2019-10-11 due-trials
Reported results 2009-014344-11 Neuroprotective effects of hypothermia combined with inhaled xenon following perinatal asphyxia - the TOBY Xe trial 2014-09-30 due-trials
Reported results 2009-016278-34 UMPIRE - Use of a Multidrug Pill In Reducing cv Events - a randomised controlled trial of fixed dose combination medication and usual care in those at high risk of cardiovascular disease. 2012-07-31 due-trials
Reported results 2009-016678-34 Exploring the Relationship Between Insulin Resistance and Interferon Resistance: Options to Overcome HCV Non-Response to Pegylated Interferon 2009-12-01 due-trials
Reported results 2009-016731-34 Amino acid regimen and intravenous lipid composition in preterm parenteral nutrition: a randomised double blind controlled trial of Nutritional Evaluation and Optimisation in Neonates. 2013-12-23 due-trials
Reported results 2009-017636-41 Vasopressin and Corticosteroids in Septic Shock 2012-05-30 due-trials
Reported results 2010-018963-40 A multi-centre, double-blind, individually randomised, placebo-controlled, parallel arm RCT with 12-week follow-up to establish the clinical and cost effectiveness of amisulpride augmentation of cloza... 2015-03-25 due-trials
Reported results 2010-020226-17 An evaluation of the effect of an angiotensin-converting enzyme (ACE) inhibitor on the growth rate of small abdominal aortic aneurysms 2015-04-14 due-trials
Reported results 2010-020440-35 GR activity in induced sputum macrophages, and a change in inflammatory biomarkers 2-hours after a single dose of either Symbicort®/Budesonide/Formoterol or placebo in Chronic Obstructive Pulmonary Di... 2014-08-18 due-trials
Reported results Terminated 2010-021515-17 RiFL: Rifaxamin in Fatty Liver Disease. Does Modulation of Gut Microbiota Reduce Hepatic Inflammation in Non-Alcoholic Steatohepatitis (NASH)? 2012-09-24 due-trials
Reported results 2010-023325-37 UMPIRE Trial sub-study - Polypill Effects on Sub Clinical Atherosclerosis (PESCA): A randomised controlled trial of a cardiovascular polypill treatment strategy compared with usual care on carotid int... 2013-01-01 due-trials
Reported results 2010-023875-24 Anglo-Scandinavian Cardiac Outcomes Trial; Post Trial Follow-Up Study 2015-05-30 due-trials
Reported results Terminated 2010-024048-14 A randomised-controlled trial of donepezil for motor recovery in acute stroke 2015-01-01 due-trials
Reported results 2010-024585-22 What is the effect of intravenous iron supplementation on cardiopulmonary haemodynamics, exercise capacity and quality of life in patients with IPAH and iron deficiency? 2017-12-22 due-trials
Reported results 2011-000454-32 A single arm phase IIa study (with combination safety run-in) to assess the safety and efficacy of AZD4547 in combination with either anastrozole or letrozole in ER positive breast cancer patients who... 2018-08-14 due-trials
Reported results 2011-001093-26 A Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Oral Azithromycin (500 Mg OD) as a Supplement to Standard Care for Adult Patients with Acute Exacerbations of Asthma 2014-06-30 due-trials
Reported results 2011-001148-31 A pilot clinical trial with the iron chelator Deferiprone in Parkinson's disease 2014-12-04 due-trials
Reported results 2011-001312-59 A double-blinded, randomized, crossover clinical study to assess the efficacy of Qutenza (capsaicin 8% patches) for the reduction of site pain caused by continuous subcutaneous infusion of Remodulin (... 2012-07-24 due-trials
Reported results 2011-002598-49 The AXitinib MicroBubble UltraSound in metastatic Colorectal cancer trial 2018-12-01 due-trials
Reported results 2011-002656-14 A randomised, prospective study, assessing changes in cerebral function in treatment naive HIV-1 infected subjects commencing either boosted atazanavir with Truvada or boosted darunavir with maraviroc... 2015-10-20 due-trials
Other 2011-002744-27 Pharmacodynamic Studies of a Histone Deacetylase Inhibitor in FRDA not-yet-due
Reported results 2011-004192-37 Hellenic Anglo Research into Morning Or Night antihypertensive drug deliverY trial. 2015-07-30 due-trials
Reported results 2011-004761-33 A randomised double-blind placebo-controlled Phase 2B clinical trial of repeated application of gene therapy in patients with cystic fibrosis 2014-05-30 due-trials
Reported results Terminated 2011-005240-10 A phase II, open label, preoperative study to assess the efficacy of the novel steroid sulfatase inhibitor Irosustat in postmenopausal women with early oestrogen receptor positive breast cancer. 2014-11-26 due-trials
Reported results 2011-005363-24 Vasopressin vs Noradrenaline as Initial therapy in Septic Shock 2015-06-03 due-trials
Reported results 2011-005544-10 Improving Inhaler Treatment and Small Airways Assessment in Chronic Obstructive Pulmonary Disease 2017-10-30 due-trials
Reported results 2011-005680-25 A Phase II study to assess the safety and efficacy of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER positive locally advanced or metastatic breast cancer patient... 2014-12-17 due-trials
Reported results 2012-000413-36 ACE-EPIC: ACE inhibitors to enhance the effects of pulmonary rehabilitation in COPD 2015-07-01 due-trials
Reported results 2012-000424-18 A study to assess near infrared laparoscopy with indocyanine green (ICG) for intraoperative lymphatic imaging and sentinel lymph node identification during standard surgical resection for colonic canc... 2015-10-26 due-trials
Reported results 2012-002198-72 Targeted retreatment of incompletely recovered COPD exacerbations with ciprofloxacin: a double-blind, randomised, placebo-controlled, multicentre Phase III trial 2018-02-22 due-trials
Reported results 2012-002199-15 A Phase III double-blind, randomised, placebo controlled trial of long term therapy on Exacerbation Rate in patients with stable COPD using Doxycycline 2017-07-20 due-trials
Reported results 2012-002357-35 Stem cells in Rapidly Evolving Active Multiple Sclerosis (STREAMS) 2016-05-23 due-trials
Other 2012-002969-35 Slow-wave sleep and daytime functioning in chronic fatigue syndrome: effects of sodium oxybate not-yet-due
Reported results 2012-003136-23 Lamotrigine And Borderline Personality Disorder: Investigating Long-Term Effectiveness 2016-09-22 due-trials
Listed as ongoing, but also has a completion date 2012-003581-40 A prospective, observational study to examine the effects of ageing on the clinical outcomes of people living with HIV in England and Ireland. 2023-03-13 bad-data
Reported results 2012-003817-32 Brain muscle axis during treatment of hepatic encephalopathy with L-ornithine L-aspartate 2015-06-19 due-trials
Reported results 2012-004893-25 RITUXILUP - An open label randomised multicentre controlled trial of RITUXImab and mycophenolate mofetil (MMF) without oral steroids for the treatment of LUPus nephritis 2017-12-13 due-trials
Reported results 2012-005159-18 An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS) 2016-06-21 due-trials
Other 2013-000962-13 Evaluating the effects of the novel GLP-1 analogue, liraglutide, in patients with Alzheimer’s disease (ELAD study) not-yet-due
Reported results 2013-003196-35 Assessing the subjective intensity of oral psilocybin in patients with treatment-resistant depression: A Pilot Study 2016-09-27 due-trials
Reported results 2013-003732-72 Randomised placebo-controlled study of grass pollen allergen immunotherapy tablet (AIT) for seasonal rhinitis: time course of nasal, cutaneous and immunological outcomes 2017-03-01 due-trials
Other 2013-004333-33 Phase 1 of dose escalation of extracorporeal shockwave treatment only and in combination DPP-4 inhibitor and parathyroid hormone (non-randomised, open-labelled) & Phase II of combination treatments of... not-yet-due
Other 2014-001244-38 Preventing Recurrent Gestational Diabetes Mellitus with Early Metformin Intervention not-yet-due
Other 2014-001425-32 RIVER - Research In Viral Eradication of HIV Reservoirs, A two-arm (proof of concept) randomised phase II trial not-yet-due
Reported results Terminated 2014-003077-42 A single-centre, double-blind, randomised, placebo-controlled crossover study to evaluate the effect of solithromycin on airway inflammation in male and female patients with chronic obstructive pulmon... 2017-01-05 due-trials
Reported results 2014-003710-84 The Central Nervous System Effects of Two Different HIV-Integrase Inhibitor Containing Antiretroviral Regimens. 2016-08-02 due-trials
Reported results 2014-003923-23 GLP-1 Receptor Agonist interVentIon for poor responders afTer bariAtric Surgery: The GRAVITAS trial 2018-11-20 due-trials
Reported results Terminated 2014-004112-11 ALERT: A phase II study of alternating eribulin and hormonal therapy in pre-treated ER+ve breast cancer 2018-07-24 due-trials
Exempt, with results 2015-001023-23 A Phase I clinical trial to assess the safety and immunogenicity of HIV DNA-C CN54ENV immunisations administered via the Intramuscular and Intradermal methods with and without electroporation followed... 2017-12-22 not-yet-due
Reported results 2015-001553-32 Neurokinin 3 Receptor Antagonism as a Novel Treatment for Menopausal Hot Flushes 2018-04-30 due-trials
Reported results 2015-001615-13 TARGETING OF THE SMALL AIRWAYS IN PATIENTS WITH COPD: AIRWAY EFFECTS OF TIOTROPIUM -Respimat vs. Handihaler 2018-01-11 due-trials
Reported results 2015-002309-12 A randomised controlled trial of the sulfonylurea Gliclazide and the DPP4 inhibitor Linagliptin on the frequency of hypoglycaemia among patients with Type 2 Diabetes and chronic kidney disease (CKD) s... 2019-06-08 due-trials
Reported results 2015-002555-10 Effect of the CRTH2 antagonist OC459 on the response to rhinovirus challenge in asthma 2018-01-18 due-trials
Reported results Terminated 2015-002955-85 A feasibility study to assess the effects of AntiretroViral Intensification with Cenicriviroc for the management of HIV-associated Cognitive Impairment. The AVICCI study 2017-01-06 due-trials
Reported results 2015-004109-18 Self-Assessment Method for Statin side-effects Or Nocebo (SAMSON) trial. 2020-09-18 due-trials
Reported results 2015-005004-28 Stratified Treatment OPtimisation for HCV-1 (STOPHCV-1) 2019-04-04 due-trials
Ongoing 2016-000065-23 An international multi-centre randomised phase II study to assess the efficacy of TAK228 in combination with intravenous weekly paclitaxel compared with weekly paclitaxel alone in women with advanced/... not-yet-due
Other 2016-001010-17 Nucleos(t)ide withdrawal in HBeAg negative hepatitis B virus infection to promote HBsAg clearance. (NUC-B) not-yet-due
Other 2016-002547-42 Open-Label Proof of Concept Feasibility Study to Explore the Safety, Tolerability and Potential Role of MDMA-Assisted Psychotherapy for the Treatment of Detoxified Patients with Alcohol Use Disorder. not-yet-due
Other 2016-002598-36 Randomised Clinical Trial of Noradrenergic Add-on Therapy with Extended-Release Guanfacine in Alzheimer's Disease not-yet-due
Other 2016-002628-96 A multi-centre, double-blind, randomised, controlled clinical trial of Rifaximin to reduce infection in patients admitted to hospital with decompensated cirrhosis not-yet-due
Other 2016-004797-18 Pilot study of the GLP-1 agonist, Liraglutide, on decreasing parenteral support requirements in short bowel patients. not-yet-due
Reported results 2017-000219-18 Psilocybin vs. escitalopram for major depressive disorder: comparative mechanisms 2020-04-17 due-trials
Reported results Terminated 2017-003172-32 Maraviroc Add-On Therapy for Steatohepatitis in HIV – The MASH Study 2020-06-30 due-trials
Reported results 2017-003239-13 Pharmacokinetics of Intramuscular Adrenaline in Food-Allergic Teenagers - does dose matter? The PIMAT study 2019-04-10 due-trials
Other 2017-003724-79 IL-1 Signal Inhibition in Alcoholic Hepatitis (Isaiah) not-yet-due
Other 2018-000027-14 A Phase 2, Pilot Study to Assess the Safety and Efficacy of Fostamatinib in the Treatment Chronic Active Antibody Mediated Rejection in Renal Transplantation not-yet-due
Other 2018-000652-18 Study to compare once-daily Extended Release Tacrolimus Versus twice-daily Immediate Release Tacrolimus following renal allograft failure to Reduce the risk of Allosensitisation not-yet-due
Other 2018-001234-18 Effect of EVOlocumab on CARotid plaque composition in asymptomatic carotid artery stenosis (EVOCAR-1) not-yet-due
Other 2018-001327-39 A Phase II, Two-Stage, Trial of Pembrolizumab in Cancer of unknown primary - CUPem not-yet-due
Other 2018-001502-28 Safety and Efficacy of Prednisolone in Adrenal Insufficiency Disease (PRED-AID Study) not-yet-due
Other 2018-001755-12 A pilot double-blind, randomised, placebo-controlled, cross-over study of metformin to reduce airway glucose in stable COPD not-yet-due
Other 2018-002176-41 PREvention of STroke in Intracerebral haemorrhaGE survivors with Atrial Fibrillation (PRESTIGE-AF) not-yet-due
Reported results 2018-002470-42 Assessment of viral shedding week following administration of live attenuated influenza vaccine in children: FluSHED-2 study 2019-04-01 due-trials
Other 2018-002471-18 The clinical effectiveness and cost effectiveness of clozapine for inpatients with borderline personality disorder: randomised controlled trial not-yet-due
Other 2018-002483-11 CHOlesterol Reduction with Evolocumab and coronAry microvascuLar function: The CHORAL Flow Study not-yet-due
Other 2018-002882-20 A multicentre randomised controlled trial to assess the safety and efficacy of adding rituximab to standard of care in treating acute antibody-mediated rejection in kidney transplantation (Transplant ... not-yet-due
Other 2018-004662-33 NOVEL: Nonavalent HPV vaccine after local conservative treatment for cervical pre-invasive disease - a randomised controlled trial not-yet-due
Other 2019-001365-32 IP4- CHRONOS: Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer not-yet-due
Other 2019-002129-31 The RIO Trial: A randomised placebo controlled trial of ART plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) vs ART plus placebo in treated Primary HIV Infection on viral con... not-yet-due
Other 2019-003036-23 Mechanisms of adverse effects of long-acting beta-agonists in asthma not-yet-due
Other 2019-004054-28 Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study not-yet-due
Other 2019-004085-17 Treating severe paediatric asthma; a randomised controlled trial of mepolizumab and omalizumab (TREAT trial) not-yet-due
Other 2020-001157-48 Identifying a safe and tolerated dose of Imatinib for patients with Pulmonary Arterial Hypertension (PAH) not-yet-due
Other 2020-002476-13 A study to assess the safety and efficacy of Clazakizumab in patients with COVID-19 and kidney disease. not-yet-due